What if some of the most promising advances in cancer research are being discovered through the intelligence of plants?
In this episode of The Spectrum of Health Podcast, Dr. Christine Schaffner welcomes Sylvie Beljanski, President of The Beljanski Foundation and CEO of Maison Beljanski, for a fascinating conversation on cancer stem cells, plant-derived compounds, and the future of integrative oncology.
Sylvie shares the legacy of her father, pioneering scientist Mirko Beljanski, and discusses the groundbreaking research being funded today through The Beljanski Foundation. Together, they explore emerging studies focused on breast cancer stem cells and prostate cancer stem cells, the importance of understanding mechanisms of action, and why scientific validation is critical for building trust in natural therapies.
This conversation offers a hopeful and research-driven perspective on how plant intelligence and evidence-based natural compounds may support the future of cancer care.
In This Episode:
The story behind The Beljanski Foundation
What cancer stem cells are and why they matter
Current research on breast and prostate cancer stem cells
The role of plant intelligence in healing
Plant-derived compounds and integrative oncology
Why scientific validation of supplements is essential
Understanding mechanisms of action in natural medicine
Hope and empowerment after a cancer diagnosis
The future of research-driven integrative cancer care
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Christine Schaffner. Innehållet i podden är skapat av Dr. Christine Schaffner och inte av,
eller tillsammans med, Poddtoppen.